Mpox therapeutics in the post-STOMP/PALM era
This article summarizes the evidence behind current treatment recommendations including tecovirimat, brincidofovir, cidofovir, trifluridine, and VIGIV, as well as other investigational treatments.
Authors
- Timothy Wilkin (ORCID: https://orcid.org/0000-0001-9386-9335)
- Lily Ostrer
- Adam C. Bortner
- Katherine Promer (ORCID: https://orcid.org/0000-0002-5280-7629)
- Sara BT Brenner
Institutions
- University of California System (US)
- University of California San Diego (US)
Publication Details
- Journal
- Current Opinion in HIV and AIDS
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1097/coh.0000000000001015
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 0.00